Explore relationships

Ponazuril

Ponazuril (INN), sold by Merial, Inc., now part of Boehringer Ingelheim, under the trade name Marquis (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by coccidiaSarcocystis neurona.

Use + to expand a branch. Click a topic name to open its summary.